Sol-gel technologies reports second quarter 2023 financial results and provides corporate update

Ness ziona, israel, aug. 10, 2023 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl) (“sol-gel”), a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin conditions, and with two approved large-category dermatology products, epsolay and twyneo, today announced financial results for the second quarter ended june 30, 2023 and provided a corporate update.
SLGL Ratings Summary
SLGL Quant Ranking